Report Highlights
- The global market for home medical equipment (HME) reached $17.9 billion in 2010 and $18.9 billion in 2011. It is expected to grow to $26.2 billion by 2016, a compound annual growth rate (CAGR) of 6.7%.
- Japan’s share of the global HME market was 7.2% in 2010 and was valued at $1.3 billion, which increased to $1.4 billion in 2011. This market will further grow to $1.9 billion by the end of 2016, a CAGR of 7.4%.
- The Japanese market for home assistive devices such as wheelchairs, scooters and home care beds was worth nearly $300 million in 2010. BCC projects that this market grew to almost $306 million in 2011 and will grow to $337 billion by 2016, a CAGR of 2% between 2011 and 2016.
INTRODUCTION
Home medical equipment (HME) is a multibillion-dollar market. Since BCC published its last study of the HME market in 2010, the market has continued to evolve, as populations age and a growing number of older people wish and are financially able to live in their own homes for as long as possible, rather than going into a nursing home or other institutional care facility. These demographic and attitudinal shifts in the health care market are reinforced by technological developments such as wireless home monitoring, and economic trends, like the rising cost of institutional care and a growing receptivity to home health care among physicians and private and public insurers.
Since the prior research study was published, the market has continued to evolve, due to factors such as an aging population, increased incidence of heart disease and other conditions requiring close patient monitoring and technological developments such as wireless remote monitoring.
STUDY BACKGROUND
These trends are global, at least in advanced industrial nations. However, most published analyses of the HME market focus on the U.S. market. Since U.S. medical equipment manufacturers are among the largest suppliers to the global health care market, they need to gain the most detailed understanding of international markets for their products, including HME.
STUDY GOALS AND OBJECTIVES
This report is intended to provide an objective, quantitative analysis that addresses the global market for HME in the context of technological change and an evolving market. More specific objectives are to
- Identify and segment the main types of HME that have been commercialized to date.
- Analyze the historical and current value of shipments of each of these product segments in specified applications, end-user and geographical markets.
- Identify and evaluate the impact of demographic, technological, regulatory and other factors that will drive future demand in each of these segments.
- Forecast the value of future shipments in each segment.
- Identify promising new technologies and products still in the development and testing stage that are likely to be commercialized successfully in the next five years.
- Identify leading HME vendors.
INTENDED AUDIENCE
The report has been written for the entire medical and health care interest community, but it is tailored especially for readers with an interest in the marketing and management dimensions of home medical equipment, such as
- Manufacturers and distributors of HME.
- Regulators and health insurers.
- Investors.
- The financial and analyst community.
SCOPE AND FORMAT
This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment. Home medical equipment is defined as durable equipment (i.e., equipment with an expected service life of at least three years) that:
- Can withstand repeated use.
- Is primarily and customarily used to serve a medical purpose.
- Generally is not useful to a person in the absence of an illness or injury.
- Is not implanted inside the patient’s body.
- Is appropriate for use in the home.
- Does not require a trained medical professional to operate.
- Usually requires a doctor’s prescription to buy (e.g., excludes most canes, walkers and other elderly and disabled assistive devices).
- Generally does not include drugs and other consumables.
While the report’s coverage is global, it focuses on selected international markets for HME, including:
- North America (United States, Canada).
- European Union (France, Germany, Italy, U.K., other European countries).
- Japan.
- BRIC nations (Brazil, Russia, India, China).
- Rest of the world.
The report includes sections on the following topics:
- Major product types and applications, both commercial and developmental.
- Market size and segmentation, including historical data on sales by product type and geographical market.
- Market drivers and constraints.
- Detailed market projections through 2016.
- Patent analysis.
- Competitor profiles.
METHODOLOGY AND INFORMATION SOURCES
This study was prepared using both primary and secondary research methodologies. The findings and conclusions of this report are based on information gathered from manufacturers and distributors of HME, multilateral and government agencies, caregivers, insurance companies and other knowledgeable sources. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature and online databases to produce the baseline market estimates contained in this report.
The base year for analysis and projection is 2010. With 2010 as a baseline, market projections were developed for 2011 to 2016. These projections are based on a combination of a consensus among primary research sources and our understanding of key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section titled Detailed Market Projections.
All dollar projections presented in this report are in 2010 constant dollars.
BCC ON-LINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
- Examine the complete BCC Research catalog of market research reports and place direct orders.
- Subscribe to any of BCC Research’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for its well-known conferences.
- Request additional information on any BCC research product.
- Take advantage of special offers.
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Related Reports
Global Markets and Technologies for Home Medical Equipment
The global market for home medical equipment (HME) was worth $17.9 billion in 2010, nearly $19 billion in 2011, and is expected to reach $26.2 billion by 2016, a CAGR of 6.7%.
Medical Automation Technologies, Products and Markets
The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.
Disabled and Elderly Assistive Technologies
The U.S. market for assistive technologies is projected to grow from $39.5 billion (including eyeglasses and contact lenses) in 2010 to $41.1 billion in 2011 and $55 billion in 2016, a compound annual growth rate (CAGR) of 6% between 2011 and 2016.
Healthcare Information Technology
BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010. The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More